<?xml version="1.0" encoding="UTF-8"?>
<p>Finally the mTOR inhibitors tested to date have been inhibitors of the TORC1 pathway. This may be by-passed by the TORC2 pathway which is insensitive to this class of mTOR inhibitors, but may be sensitive to agents which produce dual inhibition.</p>
